Generate Biomedicines, Inc. (GENB) Financials
All currency values in $ millions unless otherwise noted
| Income Statement | DEC 2025 | DEC 2024 |
|---|---|---|
| Revenues | ||
| Revenue | $32 | $20 |
| Operating Income | -$235 | -$197 |
| Non-Operating | ||
| Net Interest Expense | -$1 | -$2 |
| Income Tax Expense | $0 | $0 |
| Net Income | ||
| Net Income | -$223 | -$181 |
| Per Share Data | ||
| Revenue Per Share | $0.31 | $0.20 |
| EPS (Basic) | -$2.18 | -$2.09 |
| EPS (Diluted) | -$2.18 | -$2.09 |
| Shares Outstanding | 102.3M | 102.3M |
Related stocks: Biotechnology
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.